What Makes Finch Therapeutics (FNCH) a Worthy Investment?

Arquitos Capital Management, an investment management firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. During the third quarter, the fund delivered a net return of 29.6% bringing year-to-date gains to an impressive 66.8%. Arquitos Capital Management is an unconventional hedge fund that focuses on a select group of companies. They are also prepared to hold these companies for many years, sometimes even decades, as their businesses grow and...